Aktive Positionen von Hilary Webber
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Vorsitzender | - | - |
Karriereverlauf von Hilary Webber
Ehemalige bekannte Positionen von Hilary Webber
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CANNASOUTH LIMITED | Direktor/Vorstandsmitglied | - | 01.01.2024 |
| Independent Dir/Board Member | - | 01.01.2024 |
Statistik
International
| Neuseeland | 3 |
Operativ
| Chairman | 1 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Börse
- Insiders
- Hilary Webber
- Erfahrung
